Traws Pharma (TRAW) Stock Chart & Stock Price History $4.99 -0.05 (-0.99%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends Traws Pharma Stock Price Performance5 Day Performance+1.03%1 Month Performance-12.44% Receive TRAW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Traws Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyTrue paradigm shiftI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. TRAW Stock Chart for Saturday, November, 2, 2024 TRAW Chart by TradingView Traws Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$5.04$4.99-0.98%$5.17$4.922,500 shs$9.12 million10/31/2024$4.97$5.04+1.41%$5.13$4.971,352 shs$127.55 million10/30/2024$5.05$4.97-1.58%$5.15$4.973,278 shs$125.78 million10/29/2024$4.94$5.05+2.23%$5.23$5.006,380 shs$127.80 million10/28/2024$4.96$4.94-0.30%$5.12$4.864,909 shs$125.02 million10/25/2024$5.06$4.94-2.37%$5.11$4.729,609 shs$9.04 million Get the Latest News and Ratings for TRAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Traws Pharma and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$4.86$5.06+4.12%$5.35$4.6331,139 shs$122.99 million10/23/2024$4.85$4.86+0.21%$4.91$4.7410,219 shs$8.89 million10/22/2024$4.90$4.85-1.02%$5.00$4.5033,228 shs$122.74 million10/21/2024$4.87$4.90+0.72%$5.00$4.597,474 shs$124.00 million10/18/2024$4.70$4.86+3.40%$4.93$4.683,220 shs$122.99 million10/17/2024$4.74$4.70-0.84%$4.95$4.704,932 shs$118.94 million10/16/2024$4.80$4.74-1.25%$4.96$4.5714,185 shs$119.96 million10/15/2024$5.01$4.80-4.17%$5.26$4.776,925 shs$121.47 million10/14/2024$5.22$5.01-4.04%$5.40$5.0016,396 shs$126.77 million10/11/2024$4.89$5.22+6.75%$5.30$4.894,006 shs$9.55 million10/10/2024$4.69$4.89+4.26%$4.89$4.673,558 shs$123.75 million10/09/2024$4.80$4.69-2.29%$4.80$4.449,806 shs$118.69 million10/08/2024$5.24$4.80-8.40%$5.12$4.7813,594 shs$4.85 million10/07/2024$5.53$5.24-5.32%$5.98$4.6235,462 shs$5.29 million10/04/2024$5.55$5.53-0.36%$5.84$5.475,642 shs$5.59 million10/03/2024$5.70$5.55-2.63%$5.72$5.357,784 shs$5.61 million10/02/2024$5.58$5.70+2.15%$5.70$5.139,411 shs$144.25 million10/01/2024$5.88$5.58-5.10%$5.80$5.3213,681 shs$141.21 million09/30/2024$5.74$5.88+2.44%$6.39$5.6927,845 shs$5.94 million09/27/2024$6.10$5.74-5.90%$6.60$5.6438,304 shs$145.26 million09/26/2024$7.03$6.10-13.23%$7.05$6.0023,676 shs$6.16 million09/25/2024$7.44$7.03-5.51%$7.50$6.8629,465 shs$7.10 million09/24/2024$7.50$7.44-0.80%$7.50$6.9620,931 shs$188.28 million09/23/2024N/A$7.50$7.72$6.4350,383 shs$189.80 million Related Companies Daré Bioscience Stock Chart Lumos Pharma Stock Chart Lantern Pharma Stock Chart AEON Biopharma Stock Chart ProMIS Neurosciences Stock Chart BioLineRx Stock Chart Akari Therapeutics Stock Chart Reviva Pharmaceuticals Stock Chart Marker Therapeutics Stock Chart Lipocine Stock Chart Receive TRAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Traws Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRAW) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Traws Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Traws Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
